Drug
Linaclotide
Linaclotide: highest development phase Phase 3, developed by Hansoh Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Linaclotide NCT04804267 | Phase 3 | Chronic Idiopathic Constipation |
Latest
No recent events.
Follow Linaclotide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.